Assessing Why Preanalytical Testing is Key in Performing High Quality Biomarker Studies

Time: 3:15 pm
day: Track B - Day 2 pm 2


  • Cutting-edge developments in blood-based biomarkers for neurodegenerative diseases
  • Biomarker identification using proteomics methods, including mass spectrometry and array-based proteomics technologies
  • Analytical and clinical validation for diagnostic use of the most promising biomarkers by immunoassays
  • Ensuring the quality of biosamples